169 related articles for article (PubMed ID: 27062703)
1. Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis.
Wang G; Shen W; Cui L; Chen W; Hu X; Fu J
Cancer Biomark; 2016; 16(3):459-65. PubMed ID: 27062703
[TBL] [Abstract][Full Text] [Related]
2. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
Wang D; Xu MR; Wang T; Li T; Zhu Jw
J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
[TBL] [Abstract][Full Text] [Related]
3. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
[TBL] [Abstract][Full Text] [Related]
4. Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer.
Li C; Quan J; Wei R; Zhao Z; Guan X; Liu Z; Zou S; Wang X; Jiang Z
Biomed Res Int; 2020; 2020():7532514. PubMed ID: 32596369
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.
Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C
Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503
[TBL] [Abstract][Full Text] [Related]
6. miR‑20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis.
Zhang GJ; Li Y; Zhou H; Xiao HX; Zhou T
Mol Med Rep; 2014 Jul; 10(1):283-91. PubMed ID: 24737193
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients.
Wang Z; Chen J; Zhong MZ; Huang J; Hu YP; Feng DY; Zhou ZJ; Luo X; Liu ZQ; Jiang WZ; Zhou WB
Cancer Chemother Pharmacol; 2017 Mar; 79(3):535-543. PubMed ID: 28243684
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma.
Liang PI; Chen WT; Li CF; Li CC; Li WM; Huang CN; Yeh HC; Ke HL; Wu WJ; Chai CY
J Clin Pathol; 2015 Dec; 68(12):1026-32. PubMed ID: 26135313
[TBL] [Abstract][Full Text] [Related]
9. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of UQCRC2 is correlated with tumor progression and poor prognosis in colorectal cancer.
Shang Y; Zhang F; Li D; Li C; Li H; Jiang Y; Zhang D
Pathol Res Pract; 2018 Oct; 214(10):1613-1620. PubMed ID: 30115536
[TBL] [Abstract][Full Text] [Related]
11. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Liu Y; Zhang M; Liang L; Li J; Chen YX
Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
[TBL] [Abstract][Full Text] [Related]
13. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
Li X; Wang F; Sun Y; Fan Q; Cui G
Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
[TBL] [Abstract][Full Text] [Related]
14. Expression of TUSC3 and its prognostic significance in colorectal cancer.
Zhu YF; Dong M
Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
[TBL] [Abstract][Full Text] [Related]
15. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
17. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
[TBL] [Abstract][Full Text] [Related]
18. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.
Ren YK; Xiao Y; Wan XB; Zhao YZ; Li J; Li Y; Han GS; Chen XB; Zou QY; Wang GC; Lu CM; Xu YC; Wang YC
Int J Clin Exp Pathol; 2015; 8(9):11458-63. PubMed ID: 26617875
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]